Clinical Trial Update: Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial compares neoadjuvant therapy followed by surgery versus upfront surgery for resectable pancreatic and periampullary cancers, and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Periampullary Cancer

Snippet

Sponsor: Minia University | Conditions: Pancreas Cancer, Periampullary Cancer | Phase 3 | Status: RECRUITING